News

The cannabis stock has struggled despite Tilray achieving solid growth in its most recent fiscal year.

Tilray said it will move production from the Terrapin site in Georgia "to other breweries within our network".

Download the Complete Report Here Aurora Cannabis Inc. (ACB) International Medical Growth Absorbs Much of Canadian Pricing Reset; Safari and Germany Momentum Strengthen the Medium-Term Growth Outlook. Attractively Valued. Key Takeaways: International medical cannabis revenue increased 17% to C$43.3 million in 1Q FY27, reinforcing ACB’s leadership across global medical markets. Adjusted gross margin reached 58%, […] The post Why Aurora Cannabis Looks Cheaper Than Its International Growth Suggests

Why Tilray Brands stock is back on investors’ radar Tilray Brands (TLRY) has drawn fresh attention after launching its Mollo Lite Blackberry Lemon Seltzer 4-Pack, the first light THC multipack under the Mollo label in Canada’s cannabis beverage market. See our latest analysis for Tilray Brands. For investors watching Tilray Brands, the recent Mollo Lite launch comes after a mixed share price story, with a 1-day share price return of 3.04% and a 30-day share price return of 4.69%. This sits...

The company's true organic growth is difficult to gauge given its high dependency on acquisitions.

Tilray's distribution segment was the only one that generated double-digit growth in its most recent fiscal year.

Key Takeaways; Cannabis Sector Vireo Growth to Acquire Planet 13 in Landmark All-Stock Deal SNDL Completed Parallel Asset Acquisition, Expanding its U.S. Medical Cannabis Footprint Tilray Posted Record FY2026 Revenue as Cannabis Sales Rose and Losses Narrowed Key Takeaways; Psychedelic Sector Eli Lilly’s $3.8 Billion Deal to Acquire AtaiBeckley Signals a Major Push into Psychedelic-Inspired […]

Tilray Inc (NASDAQ:TLRY) is making progress in its transition into a diversified consumer products company, according to Jefferies, which reiterated its ‘Buy’ rating while lowering its price target to $19 from a higher prior target after cutting earnings forecasts. Shares traded up almost 3%...

Moby summary of Tilray Brands, Inc.'s Q4 2026 earnings call

Tilray Brands Inc (TLRY) reports significant financial improvements and outlines strategic plans for future expansion across diverse sectors.

Tilray Brands (TLRY) delivered earnings and revenue surprises of -2,050.00% and +9.14%, respectively, for the quarter ended May 2026. Do the numbers hold clues to what lies ahead for the stock?

Tilray Brands (NASDAQ:TLRY) reported record fiscal 2026 revenue and adjusted EBITDA, supported by growth in international cannabis, pharmaceutical distribution, wellness and the fourth-quarter acquisition of BrewDog. For the fiscal year ended May 31, 2026, net revenue rose 11% to $915.5 million fro

Legal hurdle, AI spending and profit concerns weighed on sentiment.

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.23, moving 1.63% from the previous trading session.

Tilray will release its year-end numbers next week, which could have a significant impact on the stock.

The president directed federal authorities to reschedule medical marijuana.

Mr Watt said 43,000 so-called equity punk investors had joined forces for the bid.

The founder of BrewDog has launched an attempt to buy back the craft beer company months after it was rescued from administration by a US cannabis producer.

Watt posted news of his offer for BrewDog, now owned by US-listed Tilray Brands, on LinkedIn.

Aurora Cannabis' shares plunge 28% in three months as a cautious fiscal 2027 outlook overshadows record medical cannabis growth and global expansion.

Tilray Brands, Inc. (TLRY) closed at $4.38 in the latest trading session, marking a -1.79% move from the prior day.

Village Farms has slid 27% in three months despite strong international cannabis growth. Can European expansion outweigh rising competition and pricing risks?

The cannabis stock recently hit a new 52-week low.

Tilray Brands, Inc. (TLRY) closed the most recent trading day at $4.31, moving 1.6% from the previous trading session.

A financial engineering move raised its ever-growing share count.

Tilray's future extends beyond one regulatory hearing.

Key Takeaways; Cannabis Sector Tilray Brands Expanded Medical Cannabis Platform with HelloMD Acquisition Vireo Growth Entered Pennsylvania with $20 Million Retail License Deal Key Takeaways; Psychedelic Sector Optimi Health Shipped Third Commercial Psilocybin Export to Australia Helus Pharma Reported Wider Fiscal Year 2026 Loss as Lead Depression Drug Advances Toward Phase 3 Readout Clearmind Medicine […]

Tilray Brands, Inc. (NASDAQ:TLRY), backed by significant analyst-implied upside, ranks among the overlooked penny stocks to buy right now. A fresh acquisition aimed at deepening its medical cannabis footprint in Canada is giving investors a new angle on the stock despite a steep year-to-date selloff. On June 29, 2026, Tilray Brands, Inc. (NASDAQ:TLRY) announced the […]

There are much better ways to spend $5.

Tilray expands its medical cannabis strategy with HelloMD, adding virtual patient access as investors weigh growth potential against ongoing profitability challenges.